RADELUMIN 1300 MBq/ml, solution for injection bottle, 15 ml
Active ingredients: [18F]PSMA-1007
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RADELUMIN 1300 MBq/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre multidose(s) de 15 ml
- Marketing authorisation holder
- ABX ADVANCED BIOCHEMICAL COMPOUNDS BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Dec 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
64034289CIP75508614CIP133400955086147Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| [18F]PSMA-1007solution | 1300 MBq à la date et à l'heure de calibration · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.